This is an index of side effect / adverse reaction reports (a.k.a. adverse event reports) related to Visipaque (Iodine Intravascular) and submitted to the FDA during the sample period of about a year. The information is not vetted and should not be considered as verified clinical evidence.
Reports by Event Outcome
All Cases (74)
Death (6)
Life Threatening Events (12)
Disability (3)
Reports by Reaction Type
Pyrexia (10),
Renal Failure Acute (10),
Infusion Site Extravasation (7),
Hyperkalaemia (6),
Headache (6),
Lactic Acidosis (6),
Nausea (6),
Diarrhoea (6),
Abdominal Pain (5),
Confusional State (5),
Chills (5),
Pain (5)
Below are a few examples of reports where side effects / adverse reactions may be related to Visipaque (Iodine Intravascular). For a complete list or a specific selection of reports, please use the links above.
Possible Visipaque side effects in female
Reported by a health professional (non-physician/pharmacist) from France on 2012-08-27
Patient: female
Reactions: Speech Disorder, Syncope, Dyspnoea, Pelvic Pain, Micturition Urgency, Loss of Consciousness
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Visipaque
Indication: Varicocele Ovarian
Start date: 2012-06-06
End date: 2012-06-06
Aetoxisclerol 3%
Possible Visipaque side effects in male
Reported by a physician from France on 2012-08-24
Patient: male
Reactions: Vasculitis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Visipaque
Dosage: dose not reported
Indication: Therapeutic Embolisation
Start date: 2012-07-09
End date: 2012-07-09
Visipaque
Dosage: dose not reported
Start date: 2012-07-10
End date: 2012-07-10
Possible Visipaque side effects in male
Reported by a physician from France on 2012-08-15
Patient: male
Reactions: Vasculitis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Visipaque
Dosage: dose not reported
Indication: Therapeutic Embolisation
Start date: 2012-07-09
End date: 2012-07-09
Visipaque
Dosage: dose not reported
Start date: 2012-07-10
End date: 2012-07-10
Possible Visipaque side effects in 72 year old female
Reported by a health professional (non-physician/pharmacist) from Canada on 2012-08-13
Patient: 72 year old female
Reactions: Burning Sensation, Vomiting, Nausea, Anaphylactic Reaction, Chest Pain, Swollen Tongue
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Visipaque
Indication: Liver Disorder
Start date: 2012-07-30
End date: 2012-07-30
Visipaque
Indication: Diagnostic Procedure
Possible Visipaque side effects in female
Reported by a physician from France on 2012-08-09
Patient: female, weighing 56.5 kg (124.3 pounds)
Reactions: Dysgeusia, Weight Decreased, Fatigue, Nausea, Headache, Salivary Hypersecretion, Decreased Appetite
Drug(s) suspected as cause:
Visipaque
Other drugs received by patient: Altim
Possible Visipaque side effects in 30 year old female
Reported by a physician from Spain on 2012-08-01
Patient: 30 year old female
Reactions: Eyelid Oedema, Dyspnoea, Pruritus, Laryngeal Oedema, Papule, Cough
Drug(s) suspected as cause:
Visipaque
Possible Visipaque side effects in 52 year old male
Reported by a physician from Ukraine on 2012-07-31
Patient: 52 year old male
Reactions: Back Pain, Body Temperature Increased, Chills, Asthenia, Cold Sweat, Blood Pressure Decreased
Drug(s) suspected as cause:
Visipaque
Possible Visipaque side effects in female
Reported by a physician from France on 2012-07-31
Patient: female, weighing 56.5 kg (124.3 pounds)
Reactions: Dysgeusia, Weight Decreased, Fatigue, Nausea, Headache, Decreased Appetite
Drug(s) suspected as cause:
Visipaque
Other drugs received by patient: Altim
Possible Visipaque side effects in female
Reported by a physician from France on 2012-07-31
Patient: female, weighing 56.5 kg (124.3 pounds)
Reactions: Weight Decreased, Dysgeusia, Fatigue, Nausea, Headache, Decreased Appetite
Drug(s) suspected as cause:
Visipaque
Other drugs received by patient: Altim
Possible Visipaque side effects in 54 year old male
Reported by a pharmacist from United States on 2012-07-27
Patient: 54 year old male, weighing 122.3 kg (269.1 pounds)
Reactions: Coagulopathy, International Normalised Ratio Increased, Wound, Gangrene, TOE Amputation, Renal Failure Acute
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Visipaque
Dosage: 320ml once iv recent
Indication: Scan With Contrast
Lovenox
Dosage: 120mg once iv recent
Warfarin Sodium
Dosage: 12.5 mg po qd chronic
Administration route: Oral
Indication: Peripheral Arterial Occlusive Disease
Other drugs received by patient: Norvasc; Vitamin D; Plavix; Novolog; Furosemide; Carvedilol; Lipitor; Warfarin Sodium; Metolazone; Metformin Hydrochloride; Diovan; Aspirin; Lantus
Possible Visipaque side effects in 81 year old female
Reported by a pharmacist from United States on 2012-07-27
Patient: 81 year old female, weighing 86.4 kg (190.1 pounds)
Reactions: Pain in Extremity, Dermatitis Exfoliative, Renal Failure Acute
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Doripenem
Dosage: 250 mg q12h ivpb recent
Indication: Urinary Tract Infection
Visipaque
Dosage: 100 m iv recent
Indication: Scan With Contrast
Other drugs received by patient: Cyanocobalamin; Aspirin; Coumadin; Benadryl; Ventolin; Proventil; Tylenol; **drug Illegible**
Possible Visipaque side effects in female
Reported by a health professional (non-physician/pharmacist) from Denmark on 2012-07-20
Patient: female, weighing 57.0 kg (125.4 pounds)
Reactions: Photosensitivity Reaction, Hyperaesthesia, Hypersensitivity, Urticaria, Urticaria Cholinergic
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Visipaque
Indication: Haematuria
Start date: 2010-12-07
End date: 2010-12-07
Visipaque
Indication: Abdominal Pain
Possible Visipaque side effects in 88 year old male
Reported by a individual with unspecified qualification from France on 2012-07-19
Patient: 88 year old male
Reactions: Rash Papular, Purpura, Toxic Skin Eruption
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Visipaque
Other drugs received by patient: Bisoprolol Fumarate; Coversyl Arginine; Sintrom; Alfuzosin Hydrochloride; Calciparine
Possible Visipaque side effects in male
Reported by a individual with unspecified qualification from France on 2012-06-19
Patient: male
Reactions: Hypersensitivity, Urticaria, Feeling Hot, Vasoplegia Syndrome
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Visipaque
Indication: Product Used FOR Unknown Indication
Start date: 2012-05-24
End date: 2012-05-24
Plavix
Other drugs received by patient: Atorvastatin; Metformin HCL; Valium; Lercanidipine; Omeprazole; Aspirin; Fluindione; Valsartan
Possible Visipaque side effects in 64 year old male
Reported by a health professional (non-physician/pharmacist) from France on 2012-06-13
Patient: 64 year old male
Reactions: Overdose, Urticaria, Feeling Hot, Vasoplegia Syndrome
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Plavix
Administration route: Oral
Start date: 2012-05-24
End date: 2012-05-24
Visipaque
Start date: 2012-05-24
End date: 2012-05-24
Other drugs received by patient: Aspirin; Atorvastatin; Valium; Valsartan; Omeprazole; Lercanidipine; Metformin HCL
Possible Visipaque side effects in 71 year old female
Reported by a health professional (non-physician/pharmacist) on 2012-06-06
Patient: 71 year old female
Reactions: Viral Rash, Idiopathic Urticaria, Post Procedural Complication, Type III Immune Complex Mediated Reaction, Rash Pruritic, Rash Erythematous, Rash Maculo-Papular, Toxic Skin Eruption
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Plavix
Dosage: (1 in 1 d)
Indication: Product Used FOR Unknown Indication
Start date: 2009-08-22
Tocopheryl Acetate (Tocopheryl Acetate)
Indication: Product Used FOR Unknown Indication
Start date: 2009-08-21
End date: 2009-08-21
Solu-Medrol
Indication: Premedication
Start date: 2009-08-21
End date: 2009-08-21
Lovenox
Dosage: subcutaneous
Indication: Premedication
Start date: 2009-08-21
End date: 2009-08-21
Repaglinide
Dosage: 1.5 mg (1.5 mg,1 in 1 d),oral
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2009-08-22
End date: 2009-08-28
Visipaque
Dosage: intravenous
Indication: Product Used FOR Unknown Indication
Start date: 2009-08-21
End date: 2009-08-21
Metformin HCL
Dosage: 500 mg thrice/day (500 mg,3 in 1 d),oral
Administration route: Oral
Indication: Type 2 Diabetes Mellitus
Start date: 2009-08-22
End date: 2009-08-28
Isosorbide Dinitrate
Indication: Premedication
Start date: 2009-08-21
End date: 2009-08-21
Betadine
Dosage: topical
Administration route: Topical
Indication: Infection Prophylaxis
Start date: 2009-08-21
End date: 2009-08-21
Isoptin
Indication: Premedication
Start date: 2009-08-21
End date: 2009-08-21
Aspirin
Dosage: (1 in 1 d),oral
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2009-08-22
Amlodipine Besylate
Dosage: (1 in 1 d),oral
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2009-08-22
Other drugs received by patient: Nordaz (Nordazepam); Havlane (Loprazolam Mesilate); Januvia (Sitaglipitn Phosphate); Ebastine; Daflon (Diosmin); Aerius (Ebastine); Polyethylene Glycol
Possible Visipaque side effects in male
Reported by a health professional (non-physician/pharmacist) from France on 2012-06-01
Patient: male
Reactions: Drug Eruption, Rash Generalised, Skin Exfoliation, Lymphopenia, Pyrexia, Purpura, Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Rifabutin
Ethambutol Hydrochloride
Colchicine
Tramadol HCL
Nefopam Hydrochloride (Acupan)
Visipaque
Indication: Product Used FOR Unknown Indication
Start date: 2011-10-13
End date: 2011-10-13
Clarithromycin
Possible Visipaque side effects in 71 year old female
Reported by a health professional (non-physician/pharmacist) from France on 2012-05-31
Patient: 71 year old female
Reactions: Pruritus, Rash Erythematous, Rash Maculo-Papular
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Isosorbide Dinitrate
Dosage: unk
Indication: Premedication
Start date: 2009-08-21
End date: 2009-08-21
Tocopheryl Acetate
Dosage: unk
Start date: 2009-08-21
End date: 2009-08-21
Isoptin
Dosage: unk
Indication: Premedication
Start date: 2009-08-21
End date: 2009-08-21
Repaglinide
Dosage: 1.5 mg, 1x/day
Administration route: Oral
Start date: 2009-08-22
End date: 2009-08-28
Aspirin
Dosage: 160 mg, 1x/day
Administration route: Oral
Start date: 2009-08-22
Amlodipine Besylate
Dosage: 10 mg, 1x/day
Administration route: Oral
Start date: 2009-08-22
Plavix
Dosage: 75 mg, 1x/day
Administration route: Oral
Start date: 2009-08-22
Metformin HCL
Dosage: 500 mg, 3x/day
Administration route: Oral
Indication: Type 2 Diabetes Mellitus
Start date: 2009-08-22
End date: 2009-08-28
Betadine
Dosage: unk
Administration route: Topical
Indication: Infection Prophylaxis
Start date: 2009-08-21
End date: 2009-08-21
Visipaque
Dosage: unk
Start date: 2009-08-21
End date: 2009-08-21
Lovenox
Dosage: unk
Indication: Premedication
Start date: 2009-08-21
End date: 2009-08-21
Solu-Medrol
Dosage: unk
Indication: Premedication
Start date: 2009-08-21
End date: 2009-08-21
Other drugs received by patient: Daflon; Januvia; Ebastine; Havlane; Polyethylene Glycol; Desloratadine; Nordaz
Possible Visipaque side effects in 71 year old female
Reported by a health professional (non-physician/pharmacist) from France on 2012-05-31
Patient: 71 year old female
Reactions: Pruritus, Idiopathic Urticaria, Rash Erythematous, Urticaria, Rash Maculo-Papular
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Metformin HCL
Dosage: 500 mg, tid, unk
Administration route: Oral
Indication: Type 2 Diabetes Mellitus
Start date: 2009-08-22
End date: 2009-08-28
Heparin
Dosage: unk
Start date: 2009-08-21
End date: 2009-08-21
Visipaque
Dosage: unk
Start date: 2009-08-21
End date: 2009-08-21
Betadine
Dosage: unk
Start date: 2009-08-21
End date: 2009-08-21
Repaglinide
Dosage: 0.5 mg, tid , unk
Administration route: Oral
Start date: 2009-08-22
End date: 2009-08-28
Aspirin
Dosage: 160.000000 mg, qd, unk
Administration route: Oral
Start date: 2009-08-22
Clopidogrel Bisulfate
Dosage: 75.000000 mg, qd, unk
Administration route: Oral
Start date: 2009-08-22
Tocopheryl Acetate
Dosage: unk
Start date: 2009-08-21
End date: 2009-08-21
Isoptin
Dosage: unk
Start date: 2009-08-21
End date: 2009-08-21
Solu-Medrol
Dosage: unk
Start date: 2009-08-21
End date: 2009-08-21
Amlodipine Besylate
Dosage: 10 mg, qd , unk
Administration route: Oral
Start date: 2009-08-22
Other drugs received by patient: Daflon; Ebastine; Loprazolam Mesilate; Macrogol
Possible Visipaque side effects in 75 year old male
Reported by a physician from Thailand on 2012-05-25
Patient: 75 year old male
Reactions: Paraplegia, Pancytopenia, Hepatitis, Anuria
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Visipaque
Indication: Colon Cancer
Visipaque
Indication: Flatulence
Start date: 2010-01-26
End date: 2010-01-26
Other drugs received by patient: Furosemide; Senna Alexandrina (Senokot); Lorazepam; Aspirin; Colchicine; Bisoprolol Fumarate (Concor); Lipitor; Manidipine Hydrochloride (Madiplot); Allopurinol; Clarithromycin; Isosorbide Mononitrate; Trimetazidine Hydrochloride (Vastarel); Glipizide (Minidiab); Budesonide W / Formoterol Fumarate (Symbicort); Doxazosin Mesylate (Cardura XL); Omeprazole
Possible Visipaque side effects in male
Reported by a physician from Italy on 2012-05-25
Patient: male
Reactions: Pain in Extremity, Oedema Peripheral, Haematoma
Drug(s) suspected as cause:
Visipaque
Other drugs received by patient: Lansoprazole; Prednisone (Deltacortene); Ticlopidine HCL; Chlorpheniramine Maleate (Trimeton)
Possible Visipaque side effects in male
Reported by a physician from France on 2012-05-25
Patient: male
Reactions: Rash Generalised, Skin Exfoliation, Drug Ineffective, Adverse Drug Reaction, General Physical Health Deterioration, Purpura, Pyrexia, Hyperhidrosis, Erythema, Liver Function Test Abnormal, Neutropenia, Leukopenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Clarithromycin
Start date: 2011-11-14
Ethambutol Hydrochloride
Administration route: Oral
Indication: Atypical Mycobacterial Infection
Start date: 2011-10-07
End date: 2011-10-13
Tramadol HCL
Administration route: Oral
Indication: Arthralgia
Start date: 2011-09-24
End date: 2011-10-17
Visipaque
Dosage: once
Indication: Product Used FOR Unknown Indication
Start date: 2011-10-13
Rifabutin
Administration route: Oral
Indication: Atypical Mycobacterial Infection
Start date: 2011-10-07
End date: 2011-10-13
Ethambutol Hydrochloride
Start date: 2011-11-17
Ethambutol Hydrochloride
Start date: 2011-10-15
End date: 2011-10-17
Colchicine
Dosage: 3 1st day; 2 2nd + 3rd day; 1 since 4th
Administration route: Oral
Indication: Arthralgia
Start date: 2011-10-04
End date: 2011-10-17
Rifabutin
Start date: 2011-10-15
End date: 2011-10-17
Rifabutin
Start date: 2011-11-20
Clarithromycin
Administration route: Oral
Indication: Atypical Mycobacterial Infection
Start date: 2011-10-07
End date: 2011-10-13
Acupan
Administration route: Oral
Indication: Pain
Start date: 2011-10-03
End date: 2011-10-07
Clarithromycin
Start date: 2011-10-15
End date: 2011-10-17
Possible Visipaque side effects in 47 year old male
Reported by a consumer/non-health professional from United States on 2012-05-11
Patient: 47 year old male, weighing 63.5 kg (139.7 pounds)
Reactions: Bone Pain, Musculoskeletal Chest Pain
Drug(s) suspected as cause:
Prohance
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2012-04-13
End date: 2012-04-13
Visipaque
Indication: Computerised Tomogram
Start date: 2012-04-06
End date: 2012-04-06
Possible Visipaque side effects in 28 year old male
Reported by a individual with unspecified qualification from France on 2012-05-03
Patient: 28 year old male
Reactions: Malaise, Bradycardia
Drug(s) suspected as cause:
Visipaque
Other drugs received by patient: Lidocaine
Possible Visipaque side effects in female
Reported by a health professional (non-physician/pharmacist) from Denmark on 2012-04-18
Patient: female, weighing 60.0 kg (132.0 pounds)
Reactions: Anaphylactoid Shock
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Visipaque
Possible Visipaque side effects in 68 year old male
Reported by a pharmacist from United States on 2012-04-04
Patient: 68 year old male, weighing 120.6 kg (265.3 pounds)
Reactions: Gastrointestinal Haemorrhage, Dehydration, Contrast Media Reaction, Renal Failure Acute
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Aspirin
Dosage: 81mg daily po chronic
Administration route: Oral
Indication: Coronary Artery Disease
Plavix
Dosage: 75mg / daily / po recent
Administration route: Oral
Indication: Stent Placement
Visipaque
Dosage: recent
Other drugs received by patient: Ferrous Sulfate TAB; Coreg; Bicalutamide; VIT D3; Calcium Carbonate; Lasix; Percocet; Humalog
Possible Visipaque side effects in 59 year old female
Reported by a health professional (non-physician/pharmacist) from France on 2012-04-03
Patient: 59 year old female
Reactions: Angioedema, Dermatitis Bullous, Rash
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Visipaque
Other drugs received by patient: Neurontin; Paroxetine Hydrochloride
Possible Visipaque side effects in male
Reported by a health professional (non-physician/pharmacist) from France on 2012-03-30
Patient: male
Reactions: Nausea, Clonus, Bradycardia, Hypoaesthesia, Cardiac Arrest, Neurogenic Shock
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Aetoxisclerol
Start date: 2010-11-09
End date: 2010-11-09
Visipaque
Indication: Varicocele Repair
Start date: 2010-11-09
End date: 2010-11-09
Other drugs received by patient: Lidocaine
Possible Visipaque side effects in male
Reported by a physician from France on 2012-03-12
Patient: male
Reactions: Hypotension, Respiratory Arrest, Bradycardia, Erythema, Cardiac Arrest
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Heparin Sodium
Indication: Arteriogram Coronary
Start date: 2012-02-03
End date: 2012-02-03
Xylocaine
Dosage: once/single administration
Indication: Arteriogram Coronary
Start date: 2012-02-03
End date: 2012-02-03
Visipaque
Dosage: 270 mg of iodine / ml, 210 ml once/single administration
Indication: Arteriogram Coronary
Start date: 2012-02-03
End date: 2012-02-03
Isoptin
Dosage: 5 mg / 2 ml, 1 df once/single administration
Indication: Arteriogram Coronary
Start date: 2012-02-03
End date: 2012-02-03
Other drugs received by patient: Clopidogrel Bisulfate and Aspirin; Carvedilol; Isosorbide Dinitrate; Perindopril Erbumine; Atorvastatin; Nexium
Possible Visipaque side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-06
Patient: male
Reactions: Cardio-Respiratory Arrest
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Visipaque
Dosage: 30 ml, 1 in 1 total
Indication: Product Used FOR Unknown Indication
Start date: 2012-02-21
End date: 2012-02-21
Hexabrix
Dosage: 24 ml, 1 in 1 total
Indication: Product Used FOR Unknown Indication
Start date: 2012-02-21
End date: 2012-02-21
|